Ads
    Related paper
  1. Neutrophil Gelatinase-Associated Lipocalin (NGAL): A Promising Biomarker for Cancer Diagnosis and A Potential Target for Cancer Therapeutics
  2. Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker of Iron Deficiency in Hemodialysis Patients
  3. Neutrophil Gelatinase Associated Lipocalin-Ngal: An Emerging Biomarker for Acute Kidney Injury
  4. NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) IN RELATION TO RENAL ANEMIAOF HEMODIALYSIS PATIENTS
  5. SERUM NEUTROPHIL GELATINASE - ASSOCIATED LIPOCALIN (NGAL) AS A MARKER OF TUBULOINTERSTITIAL DAMAGE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
  6. Urine neutrophil gelatinase associated lipocalin (NGAL) in septic versus non-septic acute kidney injury
  7. Serum neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in subjects undergoing percutaneous transluminal coronary angiogram with normal EGFR
  8. Mucin Level as a Potential Biomarker for Breast Cancer Diagnosis
  9. CLINICAL UTILITY OF URINE NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (UNGAL) AS A MARKER IN DISCRIMINATION OF SEPTIC VERSUS NON-SEPTIC ACUTE KIDNEY INJURY
  10. Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-